Prime Medicine
John Maynes has a solid background in lab operations and management. John is currently working at Prime Medicine, Inc. as the Associate Director of Lab Operations, responsible for overseeing lab operations. Prior to their current role, they served as the Senior Lab Manager at Prime Medicine, Inc.
Before joining Prime Medicine, Inc., John worked at Voyager Therapeutics, Inc. as the Manager of Lab Operations. In this role, they managed a team of lab operations and EHS associates, negotiated pricing agreements for lab services, and played a key role in developing COVID operating procedures and plans.
Prior to their time at Voyager Therapeutics, Inc., John worked at KSQ Therapeutics, Inc. as a Lab Manager. John collaborated with various teams in the company to ensure the safe and efficient operation of the lab, and successfully negotiated reduced pricing on lab supplies and equipment.
Earlier in their career, John worked at Merrimack Pharmaceuticals as a Clinical Trial Associate and Laboratory Assistant. In these roles, they provided logistical support for clinical trials, managed inventory and resources, and maintained documentation for lab equipment.
Overall, John Maynes has demonstrated expertise in lab operations, team management, negotiation, and ensuring compliance with safety protocols.
John Maynes attended the University of Massachusetts Amherst from 2005 to 2010, where they obtained a Bachelor's degree in Philosophy.
This person is not in any offices
Prime Medicine
4 followers
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.